MoonLake Immunotherapeutics (MLTX)Healthcare | Biotechnology | Zug, Switzerland | NasdaqCM
18.34 USD
+0.55
(3.092%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 18.33 -0.01 (-0.010%) ⇩ (April 17, 2026, 7:58 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:03 p.m. EDT
MLTX is a high-risk, high-reward biotech stock with a volatile price history and no dividend payouts. While the stock has shown some recent momentum and there are positive analyst recommendations, the company's financials are weak with negative earnings and a high debt-to-equity ratio. Short-term traders may find opportunities in the current price range, but long-term investors should be cautious due to the lack of fundamentals and the high risk involved. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.060467 |
| AutoETS | 0.065389 |
| AutoARIMA | 0.065481 |
| AutoTheta | 0.086945 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 72% |
| H-stat | 1.24 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.501 |
| Excess Kurtosis | -0.85 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 24.865 |
| Market Cap | 1,315,489,152 |
| Forward P/E | -5.06 |
| Beta | 1.19 |
| Website | https://www.moonlaketx.com |
As of April 11, 2026, 4:03 p.m. EDT: Options activity indicates mixed sentiment. Calls show a concentration of open interest around the 17.0 and 18.0 strike prices, suggesting potential for upward movement, while puts have notable open interest at the 16.0 and 17.0 strikes, indicating caution. The high IV spikes on certain expirations suggest increased volatility and uncertainty, which could be due to upcoming earnings or news events. Overall, the options market is showing a balance between bullish and bearish positioning, with no clear consensus on the direction of the stock.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.55525 |
| Address1 | Dorfstrasse 29 |
| All Time High | 64.98 |
| All Time Low | 4.25 |
| Ask | 18.4 |
| Ask Size | 1 |
| Average Analyst Rating | 1.8 - Buy |
| Average Daily Volume10 Day | 1,231,370 |
| Average Daily Volume3 Month | 1,262,540 |
| Average Volume | 1,262,540 |
| Average Volume10Days | 1,231,370 |
| Beta | 1.189 |
| Bid | 18.26 |
| Bid Size | 1 |
| Book Value | 4.266 |
| City | Zug |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | Switzerland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 18.34 |
| Current Ratio | 9.272 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 18.57 |
| Day Low | 18.15 |
| Debt To Equity | 24.865 |
| Earnings Timestamp | 1,772,026,200 |
| Earnings Timestamp End | 1,778,502,600 |
| Earnings Timestamp Start | 1,778,502,600 |
| Ebitda | -242,218,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.117 |
| Enterprise Value | 997,229,248 |
| Eps Current Year | -3.71569 |
| Eps Forward | -3.62431 |
| Eps Trailing Twelve Months | -3.64 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 17.3448 |
| Fifty Day Average Change | 0.9951992 |
| Fifty Day Average Change Percent | 0.05737738 |
| Fifty Two Week Change Percent | -55.524998 |
| Fifty Two Week High | 62.75 |
| Fifty Two Week High Change | -44.41 |
| Fifty Two Week High Change Percent | -0.7077291 |
| Fifty Two Week Low | 5.95 |
| Fifty Two Week Low Change | 12.39 |
| Fifty Two Week Low Change Percent | 2.082353 |
| Fifty Two Week Range | 5.95 - 62.75 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,603,200,600,000 |
| Float Shares | 39,464,677 |
| Forward Eps | -3.62431 |
| Forward P E | -5.0602736 |
| Free Cashflow | -120,383,248 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 130 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.104119994 |
| Held Percent Institutions | 0.75635004 |
| Implied Shares Outstanding | 71,727,875 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland. |
| Long Name | MoonLake Immunotherapeutics |
| Market | us_market |
| Market Cap | 1,315,489,152 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_713684532 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -227,318,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,276,038,896 |
| Number Of Analyst Opinions | 14 |
| Open | 18.3 |
| Operating Cashflow | -196,007,008 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 41 415108022 |
| Post Market Change | -0.010000229 |
| Post Market Change Percent | -0.054526873 |
| Post Market Price | 18.33 |
| Post Market Time | 1,776,470,282 |
| Previous Close | 17.79 |
| Price Eps Current Year | -4.9358263 |
| Price Hint | 2 |
| Price To Book | 4.2991095 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.77 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.8125 |
| Region | US |
| Regular Market Change | 0.549999 |
| Regular Market Change Percent | 3.09162 |
| Regular Market Day High | 18.57 |
| Regular Market Day Low | 18.15 |
| Regular Market Day Range | 18.15 - 18.57 |
| Regular Market Open | 18.3 |
| Regular Market Previous Close | 17.79 |
| Regular Market Price | 18.34 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 806,217 |
| Return On Assets | -0.33916 |
| Return On Equity | -0.60780996 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 71,727,875 |
| Shares Percent Shares Out | 0.108100004 |
| Shares Short | 7,757,169 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,036,421 |
| Short Name | MoonLake Immunotherapeutics |
| Short Percent Of Float | 0.2123 |
| Short Ratio | 8.45 |
| Source Interval | 15 |
| Symbol | MLTX |
| Target High Price | 40.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 26.71429 |
| Target Median Price | 27.5 |
| Total Cash | 393,968,000 |
| Total Cash Per Share | 5.493 |
| Total Debt | 75,708,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 26.490675 |
| Two Hundred Day Average Change | -8.150675 |
| Two Hundred Day Average Change Percent | -0.3076809 |
| Type Disp | Equity |
| Volume | 806,217 |
| Website | https://www.moonlaketx.com |
| Zip | 6,300 |